Standing Committee on Vaccination

The STIKO was established in 1972 as a department of the German Federal Health Agency in Berlin. During a reorganization of the Federal Health Agency in 1994, the STIKO was attached to the Robert Koch Institute (RKI) which was now an independent Upper-level federal agency under the purview of the Federal Ministry of Health (BMG).

The legal basis for the STIKO is §20 of the Infection Protection Act (German: Infektionsschutzgesetz, or IfSG). Members of the expert body are appointed by the Federal Ministry of Health in coordination with the state ministries of health. Additional expert representatives from the Paul Ehrlich Institute, Robert Koch Institute Federal and state ministries of health attend the meetings in an advisory capacity.[1]

The commission's responsibility is to provide scientifically based recommendations regarding the necessary vaccinations in Germany. Due to the importance of the recommendations, these have been codified in the Infection Protection Act since 2001. In accordance with the goals of the Infection Protection Act, the recommendations are focused on vaccinations that are most relevant to the protection of public health.

The law does not require the commission to perform cost–benefit analysis on individual vaccinations. The commission's recommendations are based on a vaccine's risk–benefit ratio, evaluating the effectiveness of a vaccine versus any risks posed. The commission has developed criteria to minimize vaccine injuries caused by side effects.

German health insurance companies are obligated to cover the cost of any immunizations recommended by the STIKO after they have been reviewed the Federal Joint Committee (G-BA). The G-BA generally adopts the commission's recommendations, although minor differences do exist.

The members of the STIKO are appointed by the Federal Ministry of Health for a three-year term. The members serve pro bono publico.

For the period of 2017 through 2020, the commission has the following members:[2]

• Chairman: Thomas Mertens, medical director of the Institute for Virology at the University Clinic of Ulm.
• Christian Bogdan, director of the Microbiological Institute at the University Clinic of Erlangen
• Gerd-Dieter Burchard, Bernhard Nocht Institute for Tropical Medicine, Hamburg
• Edeltraut Garbe, Leibniz-Institut für Präventionsforschung und Epidemiologie, Bremen
• Ulrich Heininger, Head doctor of the Pediatric Infectiology and Vaccinology department at the University Children’s Hospital Basel (Switzerland)
• Eva Hummers-Pradier, Director of the Institute for General Medicine at Universitätsmedizin Göttingen
• Stefanie J. Klug, MPH, Chair for Epidemiology at the Technical University of Munich
• Rüdiger von Kries, Director of the Epidemiology Department and Leiter der Abteilung Epidemiologie und acting head of the Institute for Social Pediatrics at the Ludwig Maximilian University of Munich
• Thomas Ledig, general practitioner and research associate of the University Hospital Heidelberg
• Martina Littmann, Director of the Department for Infection Prevention at the State Office for Health and Social Affairs of Mecklenburg-Vorpommern, Rostock
• Jörg J. Meerpohl, Co-Director of Cochrane Deutschland at the University Medical Center Freiburg
• Marianne Röbl-Mathieu, Gynecologist, Munich
• Marianne van der Sande, Netherlands National Institute for Public Health and the Environment, Center Infectious Disease Control, Bilthoven (Netherlands)
• Martin Terhardt, Pediatrician, Berlin
• Klaus Überla, Director of the Virological Institute of University Clinic of Erlangen
• Sabine Wicker, Director of the occupational health services at the Universitätsklinikum Frankfurt at Goethe University Frankfurt
• Gudrun Widders, Ministry of Health at the district office of Spandau, Berlin
• Fred Zepp, Director of the Center for Child and Youth Medicine at the University Hospital, Johannes Gutenberg-Universität Mainz

• STIKO English homepage